Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Pharmaceutical

Health Bulletin 9/September/2022

admin by admin
September 9, 2022
in Pharmaceutical


Here are the top health news for the day:

Should Ukraine medicos be declared war victims? SC to hear matter

Demanding that Ukraine returned medicos be declared as war victims, a plea had been filed before the Supreme Court, which has listed the matter for hearing on September 12, 2022.

Filed by National Medical Forum, a national organization of doctors in India, Public Interest Litigation (PIL) under Article 32 of the Constitution of India seeks to safeguard and enforce the fundamental rights of the evacuee Indian students of war-torn Ukraine, particularly the Right to Life, Right to Education and Right to Equality enshrined and guaranteed under Article 21 and Article 21A & Article 14 of the Constitution of India.

For more details, check out the link given below:

No stipend for 7 Months: First year PG medicos of Osmania Medical College to boycott duties from September 12

Frustrated over non-payment of stipends for the last seven months, the First-year Postgraduate resident doctors belonging to Osmania Medical College have decided to initiate strike and boycott all services, excluding emergency, from September 12. 2022.

Informing the authorities about their plans to boycott services, the doctors of the medical college have asked them to clear all the dues by September 11. Interestingly, while these medicos joined their courses back in February 1, 2022, they have not received any stipend so far.

For more details, check out the link given below:

Indian pharma market sees 12.1 percent growth in august: AIOCD-AWACS report

The Indian Pharmaceutical Market (IPM) saw significant growth of 12.1 percent in value and 4.8 percent in volume, in the month of August, 2022, says market research firm All India Organization of Chemists and Druggists (AIOCD-AWACS).

“A robust 12% growth of the IPM seems to be supported by a good volume driven growth for majority of the therapy areas,” the AWACS report said. It also claimed that COVID influence had reduced drastically by July 21 last year and most of the therapies had started following the normal seasonal trends. For the month of August 22, price increase led growth seems to be slightly higher than the volume growth.

For more details, check out the link given below:

Diet soda significantly ups your chances of suffering a stroke, says study

Artificial sweeteners are widely used as no or low calorie alternatives to sugar. They are found in variety of products globally including artificially sweetened drinks, some snacks, and low calorie ready meals.



Source link

Tags: AIOCDAll India Organization of Chemists and DruggistsAWACSDiet sodaheart diseaseIndian Pharma MarketNational Medical ForumOsmania Medical CollegePG medical studentspharmastipendstrikestrokeSupreme CourtUkraine medicos
Previous Post

How to Prevent Germs With These Innovative Medical Scrubs

Next Post

J&J wins partial appeal against U.K.’s cost-effectiveness watchdog

Next Post

J&J wins partial appeal against U.K.'s cost-effectiveness watchdog

Recommended

More Common and Severe Than Expected

January 25, 2023

COVID Healthcare; Hypertension Risk; and Opioid Therapy

August 19, 2022

Don't miss it

Pharmaceutical

Mr. President, health care has a data problem

February 8, 2023
Medicines & Healthy Lifestyle

Amazon’s Virtual Health Clinic Raises Patient Privacy Issues

February 8, 2023
Medicines & Healthy Lifestyle

Know The Health Benefits Of Irish Sea Moss

February 8, 2023
News

Sharp Cutoff at Age 70

February 8, 2023
Pharmaceutical

Medical Bulletin 8/February/2023

February 8, 2023
Pharmaceutical

Biden to call for expanding caps on insulin prices

February 7, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.